NovoCure (NVCR) Asset Utilization Ratio (2015 - 2026)

NovoCure has disclosed Asset Utilization Ratio across 12 years of filings, most recently posting 0.85 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.85, up 69.61% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.85 (up 69.61% YoY), and the FY2025 annual result was 0.64, up 26.38% from the prior year.
• Asset Utilization Ratio came in at 0.85 for Q1 2026 at NovoCure, up from 0.61 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.85 in Q1 2026 to a low of 0.44 in Q2 2023.
• The 5-year median for Asset Utilization Ratio is 0.47 (2024), against an average of 0.5.
• Across the five-year window, Asset Utilization Ratio decreased 7.71% in 2023 and surged 69.61% in 2026, its largest moves.
• NovoCure's Asset Utilization Ratio stood at 0.45 in 2022, then declined by 2.27% to 0.44 in 2023, then gained by 10.61% to 0.49 in 2024, then rose by 23.15% to 0.61 in 2025, then jumped by 39.96% to 0.85 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.85 (Q1 2026), 0.61 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.